Disruption of Transcriptionally Active Stat3 Dimers with Non‐phosphorylated, Salicylic Acid‐Based Small Molecules: Potent in vitro and Tumor Cell Activities
- 12 August 2009
- journal article
- research article
- Published by Wiley in ChemBioChem
- Vol. 10 (12) , 1959-1964
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Targeting STAT3 in cancer: how successful are we?Expert Opinion on Investigational Drugs, 2008
- Targeting Protein–Protein Interactions: Suppression of Stat3 Dimerization with Rationally Designed Small‐Molecule, Nonpeptidic SH2 Domain BindersChemBioChem, 2008
- Molecular Approaches towards the Inhibition of the Signal Transducer and Activator of Transcription 3 (Stat3) ProteinChemMedChem, 2008
- Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activityProceedings of the National Academy of Sciences, 2007
- Solid-phase synthesis of Stat3 inhibitors incorporating O-carbamoylserine and O-carbamoylthreonine as glutamine mimicsBioorganic & Medicinal Chemistry Letters, 2007
- DU‐145 and PC‐3 human prostate cancer cell lines express androgen receptor: Implications for the androgen receptor functions and regulationFEBS Letters, 2006
- Targeting protein–protein interactions by rational design: mimicry of protein surfacesJournal of The Royal Society Interface, 2006
- Validating Stat3 in cancer therapyNature Medicine, 2005
- STATs in oncogenesisOncogene, 2000
- Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. CohenJournal of Molecular Biology, 1997